Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study von Goss, Glenwood, Dr Prof, Tsai, Chun-Ming, Prof, Shepherd, Frances A, Prof, Bazhenova, Lyudmila, Prof, Lee, Jong Seok, MD, Chang, Gee-Chen, MD, Crino, Lucio, MD, Satouchi, Miyako, MD, Chu, Quincy, MD, Hida, Toyoaki, MD, Han, Ji-Youn, Prof, Juan, Oscar, MD, Dunphy, Frank, Prof, Nishio, Makoto, MD, Kang, Jin-Hyoung, MD, Majem, Margarita, MD, Mann, Helen, MSc, Cantarini, Mireille, MD, Ghiorghiu, Serban, MD, Mitsudomi, Tetsuya, Prof

Volltext

Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations von Paik, Paul K, Felip, Enriqueta, Veillon, Remi, Sakai, Hiroshi, Cortot, Alexis B, Garassino, Marina C, Mazieres, Julien, Viteri, Santiago, Senellart, Helene, Van Meerbeeck, Jan, Raskin, Jo, Reinmuth, Niels, Conte, Pierfranco, Kowalski, Dariusz, Cho, Byoung Chul, Patel, Jyoti D, Horn, Leora, Griesinger, Frank, Han, Ji-Youn, Kim, Young-Chul, Chang, Gee-Chen, Tsai, Chen-Liang, Yang, James C.-H, Chen, Yuh-Min, Smit, Egbert F, van der Wekken, Anthonie J, Kato, Terufumi, Juraeva, Dilafruz, Stroh, Christopher, Bruns, Rolf, Straub, Josef, Johne, Andreas, Scheele, Jürgen, Heymach, John V, Le, Xiuning

Volltext

The Relationship Between Air Pollution and Lung Cancer in Nonsmokers in Taiwan von Tseng, Chien-Hua, Tsuang, Ben-Jei, Chiang, Chun-Ju, Ku, Kai-Chen, Tseng, Jeng-Sen, Yang, Tsung-Ying, Hsu, Kuo-Hsuan, Chen, Kun-Chieh, Yu, Sung-Liang, Lee, Wen-Chung, Liu, Tsang-Wu, Chan, Chang-Chuan, Chang, Gee-Chen

Volltext

Identification of five driver gene mutations in patients with treatment-naïve lung adenocarcinoma in Taiwan von Hsu, Kuo-Hsuan, Ho, Chao-Chi, Hsia, Te-Chun, Tseng, Jeng-Sen, Su, Kang-Yi, Wu, Ming-Fang, Chiu, Kuo-Liang, Yang, Tsung-Ying, Chen, Kun-Chieh, Ooi, Hean, Wu, Tzu-Chin, Chen, Hung-Jen, Chen, Hsuan-Yu, Chang, Chi-Sheng, Hsu, Chung-Ping, Hsia, Jiun-Yi, Chuang, Cheng-Yen, Lin, Chin-Hung, Chen, Jeremy J W, Chen, Kuan-Yu, Liao, Wei-Yu, Shih, Jin-Yuan, Yu, Sung-Liang, Yu, Chong-Jen, Yang, Pan-Chyr, Chang, Gee-Chen

Volltext

Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report von Yang, James Chih-Hsin, Shepherd, Frances A., Kim, Dong-Wan, Lee, Gyeong-Won, Lee, Jong Seok, Chang, Gee-Chen, Lee, Sung Sook, Wei, Yu-Feng, Lee, Yun Gyoo, Laus, Gianluca, Collins, Barbara, Pisetzky, Francesca, Horn, Leora

Volltext

Impact of cooking oil fume exposure and fume extractor use on lung cancer risk in non-smoking Han Chinese women von Chen, Tzu-Yu, Fang, Yao-Hwei, Chen, Hui-Ling, Chang, Chin-Hao, Huang, Hsin, Chen, Yi-Song, Liao, Kuo-Meng, Wu, Hsiao-Yu, Chang, Gee-Chen, Tsai, Ying-Huang, Wang, Chih-Liang, Chen, Yuh-Min, Huang, Ming-Shyan, Su, Wu-Chou, Yang, Pan-Chyr, Chen, Chien-Jen, Hsiao, Chin-Fu, Hsiung, Chao A.

Volltext

Reduced symmetric dimethylation stabilizes vimentin and promotes metastasis in MTAP‐deficient lung cancer von Chang, Wen‐Hsin, Chen, Yi‐Ju, Hsiao, Yi‐Jing, Chiang, Ching‐Cheng, Wang, Chia‐Yu, Chang, Ya‐Ling, Hong, Qi‐Sheng, Lin, Chien‐Yu, Lin, Shr‐Uen, Chang, Gee‐Chen, Chen, Hsuan‐Yu, Chen, Yu‐Ju, Chen, Ching‐Hsien, Yang, Pan‐Chyr, Yu, Sung‐Liang

Volltext

Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer von Su, Kang-Yi, Chen, Hsuan-Yu, Li, Ker-Chau, Kuo, Min-Liang, Yang, James Chih-Hsin, Chan, Wing-Kai, Ho, Bing-Ching, Chang, Gee-Chen, Shih, Jin-Yuan, Yu, Sung-Liang, Yang, Pan-Chyr

Volltext

MicroRNA Signature Predicts Survival and Relapse in Lung Cancer von Yu, Sung-Liang, Chen, Hsuan-Yu, Chang, Gee-Chen, Chen, Chih-Yi, Chen, Huei-Wen, Singh, Sher, Cheng, Chiou-Ling, Yu, Chong-Jen, Lee, Yung-Chie, Chen, Han-Shiang, Su, Te-Jen, Chiang, Ching-Cheng, Li, Han-Ni, Hong, Qi-Sheng, Su, Hsin-Yuan, Chen, Chun-Chieh, Chen, Wan-Jiun, Liu, Chun-Chi, Chan, Wing-Kai, Chen, Wei J., Li, Ker-Chau, Chen, Jeremy J.W., Yang, Pan-Chyr

Volltext

Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer von Lin, Sheng-Yi, Chang, Hsiu-Hui, Lai, Yi-Hua, Lin, Ching-Hsiung, Chen, Min-Hsuan, Chang, Gee-Chen, Tsai, Meng-Feng, Chen, Jeremy J W

Volltext

RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer von Chen, Mei-Chih, Chen, Kun-Chieh, Chang, Gee-Chen, Lin, Ho, Wu, Chun-Chi, Kao, Wei-Hsiang, Teng, Chieh-Lin Jerry, Hsu, Shih-Lan, Yang, Tsung-Ying

Volltext

The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M von Huang, Yen-Hsiang, Tseng, Jeng-Sen, Hsu, Kuo-Hsuan, Chen, Kun-Chieh, Su, Kang-Yi, Yu, Sung-Liang, Chen, Jeremy J. W., Yang, Tsung-Ying, Chang, Gee-Chen

Volltext

Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer von Chang, Gee-Chen, Shih, Jin-Yuan, Yu, Chong-Jen, Chao, Heng-Sheng, Yang, Cheng-Ta, Lin, Chien-Chung, Hung, Jen-Yu, Hsiao, Sheng-Yen, Wang, Chin-Chou, Chian, Chih-Feng, Hsia, Te-Chun, Chen, Yuh-Min

Volltext

A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer von Chen, Jeremy J.W, Chen, Hsuan-Yu, Chen, Chun-Houh, Chen, Chih-Yi, Chen, Wei J, Yu, Sung-Liang, Chang, Gee-Chen, Yuan, Ang, Cheng, Chiou-Ling, Wang, Chien-Hsun, Terng, Harn-Jing, Kao, Shu-Fang, Chan, Wing-Kai, Li, Han-Ni, Liu, Chun-Chi, Singh, Sher, Yang, Pan-Chyr

Volltext

Exercise experiences in patients with metastatic lung cancer: A qualitative approach von Chang, Pi-Hua, Lin, Ching-Rong, Lee, Yun-Hsiang, Liu, Yi-Lin, Chang, Gee-Chen, Hoogland, Aasha I, Lai, Yeur-Hur

Volltext

Various impacts of driver mutations on the PD-L1 expression of NSCLC von Chu, Cheng-Hsiang, Huang, Yen-Hsiang, Lee, Po-Hsin, Hsu, Kuo-Hsuan, Chen, Kun-Chieh, Su, Kang-Yi, Yu, Sung-Liang, Tseng, Jeng-Sen, Yang, Tsung-Ying, Chang, Gee-Chen

Volltext

Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial von Wu, Yi-Long, Prof, Lee, Jin Soo, MD, Thongprasert, Sumitra, MD, Yu, Chong-Jen, Prof, Zhang, Li, Prof, Ladrera, Guia, MD, Srimuninnimit, Vichien, MD, Sriuranpong, Virote, MD, Sandoval-Tan, Jennifer, MD, Zhu, Yunzhong, Prof, Liao, Meilin, Prof, Zhou, Caicun, MD, Pan, Hongming, MD, Lee, Victor, FRCR, Chen, Yuh-Min, PhD, Sun, Yan, MD, Margono, Benjamin, PhD, Fuerte, Fatima, MD, Chang, Gee-Chen, MD, Seetalarom, Kasan, MD, Wang, Jie, Prof, Cheng, Ashley, MBBS, Syahruddin, Elisna, PhD, Qian, Xiaoping, MD, Ho, James, MD, Kurnianda, Johan, SPPD, Liu, Hsingjin Eugene, MD, Jin, Kate, MD, Truman, Matt, MSc, Bara, Ilze, MD, Mok, Tony, Prof

Volltext

Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors von Lee, Po-Hsin, Yang, Tsung-Ying, Chen, Kun-Chieh, Huang, Yen-Hsiang, Tseng, Jeng-Sen, Hsu, Kuo-Hsuan, Wu, Yu-Chen, Liu, Ko-Jiunn, Chang, Gee-Chen

Volltext

Surface α-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target von Hsiao, Kuan-Chung, Shih, Neng-Yao, Fang, Hsun-Lang, Huang, Tze-Sing, Kuo, Ching-Chuan, Chu, Pei-Yi, Hung, Yi-Mei, Chou, Shao-Wen, Yang, Yi-Yuan, Chang, Gee-Chen, Liu, Ko-Jiunn

Volltext

Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis von Hung, Pei-Fang, Hong, Tse-Ming, Chang, Che-Chang, Hung, Chung-Lieh, Hsu, Yuan-Ling, Chang, Yih-Leong, Wu, Chen-Tu, Chang, Gee-Chen, Chan, Nei-Li, Yu, Sung-Liang, Yang, Pan-Chyr, Pan, Szu-Hua

Volltext